Literature DB >> 6446374

Production of migration inhibitory factor in response to bacterial and fungal antigens in patients with untreated Graves' disease.

J R Wall, E A Ryan.   

Abstract

Tests for the production of migration inhibitory factor by peripheral blood leukocytes in response to ubiquitous bacterial and fungal antigens were carried out in patients with untreated Graves' disease and in healthy control subjects. Dose-response studies, tests for the production of this factor after 72 hours' stimulation with phytohemagglutinin as a test for reserve, and tests before and after 24 hours' preculture to deplete suppressor cells were also performed in some patients. The antigens used were Candida, Trichophyton-Oidiomyces-Epidermophyton, mumps live attenuated virus and purified protein derivative of tuberculin. The production of migration inhibitory factor was measured by the agarose microdroplet method.The production of migration inhibitory factor in response to all the antigens except mumps virus was slightly greater in the patients than in the control subjects, although the differences were not significant. The dose-response characteristics and the production of migration inhibitory factor after stimulation with phytohemagglutinin were similar in the two groups. The production of migration inhibitory factor in response to suboptimal concentrations of Candida, Trichophyton-Oidiomyces-Epidermophyton and mumps virus was not enhanced in either group after 24 hours' preculture apart from a slight increase in response to mumps virus in the patients.These results fail to support the suggestion that patients with Graves' disease have a deficiency of suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446374      PMCID: PMC1802060     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  36 in total

Review 1.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

Review 2.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

3.  The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity?

Authors:  R Volpe; M Edmonds; L Lamki; P V Clarke; V V Row
Journal:  Mayo Clin Proc       Date:  1972-11       Impact factor: 7.616

4.  Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos.

Authors:  P Mashieu; R Winand
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

5.  Lymphocyte dysfunction in thyrotoxicosis.

Authors:  J I Brody; S Greenberg
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

6.  Thymic hypoplasia and thyroid dysfunction.

Authors:  R Hong; R Gatti; J C Rathbun; R A Good
Journal:  N Engl J Med       Date:  1970-02-26       Impact factor: 91.245

7.  Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus.

Authors:  N Talal
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

8.  Observations on the role of circulating lymphocytes in thyroid auto-immunity.

Authors:  L J DeGroot; S Jaksina
Journal:  J Clin Endocrinol Metab       Date:  1969-02       Impact factor: 5.958

9.  Immune cell cooperation, viruses, and antibodies to nucleic acids in New Zealand mice.

Authors:  N Talal; A D Steinberg; M E Jacobs; T M Chused; A F Gazdar
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

10.  Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).

Authors:  L Lamki; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1973-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.